Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.22.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 39,117 $ 52,886
Restricted cash, current 1,703 1,297
Contract receivables and retainage, net 26,816 15,986
Contract assets 5,185 4,759
Prepaid expenses and other assets 8,980 6,971
Inventory 1,749 1,779
Assets held for sale 1,800 1,800
Total current assets 85,350 85,478
Restricted cash, noncurrent   406
Property, plant and equipment, net 30,966 32,866
Goodwill 2,217 2,217
Other intangibles, net 913 984
Other noncurrent assets 13,554 13,322
Total assets 133,000 135,273
Current liabilities:    
Accounts payable 11,763 9,280
Contract liabilities 3,309 6,648
Accrued expenses and other liabilities 16,284 14,026
Total current liabilities 31,356 29,954
Other noncurrent liabilities 1,296 1,411
Total liabilities 32,652 31,365
Shareholders’ equity:    
Preferred stock, no par value, 5,000 shares authorized, no shares issued and outstanding
Common stock, no par value, 30,000 shares authorized, 15,923 shares issued and outstanding at June 30, 2022 and 15,622 at December 31, 2021 11,478 11,384
Additional paid-in capital 106,356 105,511
Accumulated deficit (17,486) (12,987)
Total shareholders’ equity 100,348 103,908
Total liabilities and shareholders’ equity $ 133,000 $ 135,273